Paras Patel: The Evolving Landscape of Oral Potentially Malignant Disorders

Oral Potentially Malignant Disorders (OPMDs) represent one of the most critical diagnostic and management challenges in contemporary oral and maxillofacial care. Accurate recognition, risk assessment, and timely intervention can significantly alter patient outcomes and reduce progression to oral cancer.

In this focused online lecture, Dr. Paras B. Patel, Director of Oral & Maxillofacial Pathology at ProPath and co-founder of the Center for Oral Pathology, will provide surgeons with a clinically practical, pathology-driven update on the evolving concepts in OPMDs. Drawing from his extensive experience in diagnostic and surgical pathology as well as active research in oral carcinogenesis, Dr. Patel will review current classifications, emerging risk predictors, and real-world management implications.

This session is designed to directly enhance the decision-making of surgeons involved in biopsy, surveillance, and oral cancer prevention.

SPEAKER

Paras B. Patel DDS is a board certified oral and maxillofacial pathologist, who obtained his dental degree from Howard University College of Dentistry in 2011. After graduation, he practiced general dentistry for a few years in the Lubbock area with the Community Health Center of Lubbock, as their staff dentist on the mobile dental unit. In 2014, he began his residency in oral and maxillofacial pathology at TAMU (Baylor) School of Dentistry. Upon completion of his residency, he took a position at the college of dentistry as a full-time faculty member, and after 5 years in academia, Dr. Patel transitioned into private practice and helped establish the Center for Oral Pathology, where he continues his clinical practice. He also had the opportunity to continue his practice of surgical pathology in conjunction with ProPath and helped establish the division of oral and maxillofacial pathology, where he currently serves as director. Dr. Patel also stays active in clinical research involving oral potentially malignant disorders and oral cancer.

LEARNING OBJECTIVES

After participating in this activity, surgeons will be able to:

1. Identify and differentiate the key clinical and histopathologic features of common Oral Potentially Malignant Disorders.

2. Interpret dysplasia grading and risk stratification to guide clinical management and surveillance strategies.

3. Apply evidence-based principles for biopsy timing, follow-up intervals, and referral pathways.

4. Integrate current research and evolving concepts in oral carcinogenesis into daily surgical practice.

TARGET AUDIENCE

This lecture is designed for:

• Oral & Maxillofacial Surgeons

• Head & Neck / Oncologic Surgeons

• ENT Surgeons

• Oral Medicine Specialists

• Pathology-interested Dental Specialists and Residents

• Surgeons involved in oral cancer screening, diagnosis, and management

ONLINE LIVE EVENT ( Free of Charge )

San Francisco: Monday, April 20, 2026 at 4:00 pm

Mexico City: Monday, April 20, 2026 at 5:00 pm

New York: Monday, April 20, 2026 at 7:00 pm

Rio de Janeiro: Monday, April 20, 2026 at 8:00 pm

Chicago: Monday, April 20, 2026 at 6:00 pm

Berlin: Tuesday, April 21, 2026 at 1:00 am

Johannesburg: Tuesday, April 21, 2026 at 1:00 am

Cairo: Tuesday, April 21, 2026 at 1:00 am

Dubai: Tuesday, April 21, 2026 at 3:00 am

Delhi: Tuesday, April 21, 2026 at 4:30 am

Manila: Tuesday, April 21, 2026 at 7:00 am

Sydney: Tuesday, April 21, 2026 at 9:00 am

CE ACCREDITATION

surgeOn is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. surgeOn designates this activity for 1 credit hour of continuing education credits.

This event may also be accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) for a maximum of 1 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity. If you are a learner based in the U.S. or Canada EACCME credits are recognized by the American Medical Association (AMA) and the Royal College of Physicians and Surgeons of Canada.

DECLARATION

In accordance with criterion 13 of document UEMS 2023.07.rev “EACCME® Criteria for the Accreditation of Live Educational Events (LEEs)” and the Standard v. Commercial or Promotional Conflict of Interest, published by the American Dental Association Continuing Education Recognition Program (ADA CERP), all surgeON presenters sign a Conflict of Interest form to document all perceived or actual conflicts of interest for the last 3 years, whether due to a financial or other relationship. This document can be viewed at the beginning of the event or on request by emailing info@surgeon-events.org No fee, honorarium or arrangement for re-imbursement of expenses in relation to the this event has been provided to the speaker.